Myocardial injury: where inflammation and autophagy meet

Abstract

Autophagy is a highly conserved bulk degradation mechanism that degrades damaged organelles, aged proteins and intracellular contents to maintain the homeostasis of the intracellular microenvironment. Activation of autophagy can be observed during myocardial injury, during which inflammatory responses are strongly triggered. Autophagy can inhibit the inflammatory response and regulate the inflammatory microenvironment by removing invading pathogens and damaged mitochondria. In addition, autophagy may enhance the clearance of apoptotic and necrotic cells to promote the repair of damaged tissue. In this paper, we briefly review the role of autophagy in different cell types in the inflammatory microenvironment of myocardial injury and discuss the molecular mechanism of autophagy in regulating the inflammatory response in a series of myocardial injury conditions, including myocardial ischemia, ischemia/reperfusion injury and sepsis cardiomyopathy.

Keywords

Autophagy / Inflammation / Myocardial injury

References

[1] Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020; 76: 2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010.

[2] Liu C, Chen J, Chen H, Zhang T, He D, Luo Q, et al. PCSK9 inhibition: from current advances to evolving future. Cell. 2022;11. https://doi.org/10.3390/cells11192972.

[3] Du J, Li Y, Zhao W. Autophagy and myocardial ischemia. Adv Exp Med Biol. 2020; 1207: 217-22. https://doi.org/10.1007/978-981-15-4272-5_15.

[4] Liu CP, Bayado N, He DY, Li J, Chen HQ, Li LM, et al. Therapeutic applications of extracellular vesicles for myocardial repair. Front Cardiovasc Med. 2021;8ARTN 758050. https://doi.org/10.3389/fcvm.2021.758050.

[5] Liu C, Fan Z, He D, Chen H, Zhang S, Guo S, et al. Designer functional Nanomedicine for myocardial repair by regulating the inflammatory microenvironment. Pharmaceutics. 2022; 14. https://doi.org/10.3390/pharmaceutics14040758.

[6] Dillmann WH. Diabetic cardiomyopathy. Circ Res. 2019; 124: 1160-2. https://doi.org/10.1161/CIRCRESAHA.118.314665.

[7] Higgins AY, O’Halloran TD, Chang JD. Chemotherapy-induced cardiomyopathy. Heart Fail Rev. 2015; 20: 721-30. https://doi.org/10.1007/s10741-015-9502-y.

[8] Lv X, Wang H. Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res. 2016; 3: 30. https://doi.org/10.1186/s40779-016-0099-9.

[9] Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet. 2010; 375: 752-62. https://doi.org/10.1016/S0140-6736(09)62023-7.

[10] McComb S, Thiriot A, Akache B, Krishnan L, Stark F. Introduction to the immune system. Methods Mol Biol. 2019; 2024: 1-24. https://doi.org/10.1007/978-1-4939-9597-4_1.

[11] Sun K, Li YY, Jin J. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Signal Transduct Target Ther. 2021; 6: 79. https://doi.org/10.1038/s41392-020-00455-6.

[12] Bento CF, Renna M, Ghislat G, Puri C, Ashkenazi A, Vicinanza M, et al. Mammalian autophagy: how does it work? Annu Rev Biochem. 2016; 85: 685-713. https://doi.org/10.1146/annurev-biochem-060815-014556.

[13] Liu C, Chen G, Chen Y, Dang Y, Nie G, Wu D, et al. Danlou tablets inhibit atherosclerosis in Apolipoprotein E-deficient mice by inducing macrophage autophagy: the role of the PI3K-Akt-mTOR pathway. Front Pharmacol. 2021; 12: 724670. https://doi.org/10.3389/fphar.2021.724670.

[14] Gerada C, Ryan KM. Autophagy, the innate immune response and cancer. Mol Oncol. 2020; 14: 1913-29. https://doi.org/10.1002/1878-0261.12774.

[15] Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011; 469: 323-35. https://doi.org/10.1038/nature09782.

[16] Yang Z, Goronzy JJ, Weyand CM. Autophagy in autoimmune disease. J Mol Med (Berl). 2015; 93: 707-17. https://doi.org/10.1007/s00109-015-1297-8.

[17] Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011; 147: 728-41. https://doi.org/10.1016/j.cell.2011.10.026.

[18] Yang Z, Klionsky DJ. An overview of the molecular mechanism of autophagy. Curr Top Microbiol Immunol. 2009; 335: 1-32. https://doi.org/10.1007/978-3-642-00302-8_1.

[19] Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018; 14: 207-15. https://doi.org/10.1080/15548627.2017.1378838.

[20] Heckmann BL, Green DR. LC3-associated phagocytosis at a glance. J Cell Sci. 2019; 132. https://doi.org/10.1242/jcs.222984.

[21] Boya P, Reggiori F, Codogno P. Emerging regulation and functions of autophagy. Nat Cell Biol. 2013; 15: 713-20. https://doi.org/10.1038/ncb2788.

[22] Amaravadi R, Kimmelman AC, White E. Recent insights into the function of autophagy in cancer. Genes Dev. 2016; 30: 1913-30. https://doi.org/10.1101/gad.287524.116.

[23] Mizushima N, Levine B. Autophagy in human diseases. N Engl J Med. 2020; 383: 1564-76. https://doi.org/10.1056/NEJMra2022774.

[24] Tanida I. Autophagy basics. Microbiol Immunol. 2011; 55: 1-11. https://doi.org/10.1111/j.1348-0421.2010.00271.x.

[25] Hale SL, Kloner RA. Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and arrhythmias in experimental models. Cardiovasc Drugs Ther. 2014; 28: 469-75. https://doi.org/10.1007/s10557-014-6548-3.

[26] Chanson M, Derouette JP, Roth I, Foglia B, Scerri I, Dudez T, et al. Gap junctional communication in tissue inflammation and repair. BBA-Biomembranes. 2005; 1711: 197-207. https://doi.org/10.1016/j.bbamem.2004.10.005.

[27] Entman ML, Youker K, Shoji T, Kukielka G, Shappell SB, Taylor AA, et al. Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest. 1992; 90: 1335-45. https://doi.org/10.1172/JCI115999.

[28] Kluever AK, Deindl E. Extracellular RNA, a potential drug target for alleviating atherosclerosis, ischemia/reperfusion injury and organ transplantation. Curr Pharm Biotechnol. 2018; 19: 1189-95. https://doi.org/10.2174/1389201020666190102150610.

[29] Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac Remodeling. J Am Coll Cardiol. 2000; 35: 569-82. https://doi.org/10.1016/s0735-1097(99)00630-0.

[30] White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987; 76: 44-51. https://doi.org/10.1161/01.cir.76.1.44.

[31] Briaud SA, Ding ZM, Michael LH, Entman ML, Daniel S, Ballantyne CM. Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice. Am J Physiol Heart Circ Physiol. 2001; 280: H60-7. https://doi.org/10.1152/ajpheart.2001.280.1.H60.

[32] Chen W, Saxena A, Li N, Sun J, Gupta A, Lee DW, et al. Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol. 2012; 32: 2598-608. https://doi.org/10.1161/ATVBAHA.112.300310.

[33] Ong SB, Hernandez-Resendiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018; 186: 73-87. https://doi.org/10.1016/j.pharmthera.2018.01.001.

[34] Ma K, Guo J, Wang G, Ni Q, Liu X. Toll-like receptor 2-mediated autophagy promotes microglial cell death by modulating the microglial M1/M2 phenotype. Inflammation. 2020; 43: 701-11. https://doi.org/10.1007/s10753-019-01152-5.

[35] Li XM, Jung KE, Yim SH, Hong DK, Kim CD, Hong JY, et al. Autophagy suppresses toll-like receptor 3-mediated inflammatory reaction in human epidermal keratinocytes. Biomed Res Int. 2020; 2020: 4584626. https://doi.org/10.1155/2020/4584626.

[36] Mihalache CC, Simon HU. Autophagy regulation in macrophages and neutrophils. Exp Cell Res. 2012; 318: 1187-92. https://doi.org/10.1016/j.yexcr.2011.12.021.

[37] Ye X, Zhou XJ, Zhang H. Exploring the role of autophagy-related gene 5 (ATG5) yields important insights into autophagy in autoimmune/autoinflammatory diseases. Front Immunol. 2018; 9: 2334. https://doi.org/10.3389/fimmu.2018.02334.

[38] Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012; 30: 459-89. https://doi.org/10.1146/annurev-immunol-020711-074942.

[39] Ma Y, Yabluchanskiy A, Lindsey ML. Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair. 2013; 6: 11. https://doi.org/10.1186/1755-1536-6-11.

[40] Bhattacharya A, Wei Q, Shin JN, Abdel Fattah E, Bonilla DL, Xiang Q, et al. Autophagy is required for neutrophil-mediated inflammation. Cell Rep. 2015; 12: 1731-9. https://doi.org/10.1016/j.celrep.2015.08.019.

[41] Harris J. Autophagy and cytokines. Cytokine. 2011; 56: 140-4. https://doi.org/10.1016/j.cyto.2011.08.022.

[42] Iula L, Keitelman IA, Sabbione F, Fuentes F, Guzman M, Galletti JG, et al. Autophagy mediates interleukin-1beta secretion in human neutrophils. Front Immunol. 2018; 9: 269. https://doi.org/10.3389/fimmu.2018.00269.

[43] Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010; 107: 15880-5. https://doi.org/10.1073/pnas.1005743107.

[44] Hofbauer TM, Mangold A, Scherz T, Seidl V, Panzenbock A, Ondracek AS, et al. Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction. Basic Res Cardiol. 2019; 114: 33. https://doi.org/10.1007/s00395-019-0740-3.

[45] Liu J, Yang D, Wang X, Zhu Z, Wang T, Ma A, et al. Neutrophil extracellular traps and dsDNA predict outcomes among patients with ST-elevation myocardial infarction. Sci Rep. 2019; 9: 11599. https://doi.org/10.1038/s41598-019-47853-7.

[46] Helseth R, Shetelig C, Andersen GO, Langseth MS, Limalanathan S, Opstad TB, et al. Neutrophil extracellular trap components associate with infarct size, ventricular function, and clinical outcome in STEMI. Mediat Inflamm. 2019; 2019: 7816491. https://doi.org/10.1155/2019/7816491.

[47] Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, De Rycke R, et al. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res. 2011; 21: 290-304. https://doi.org/10.1038/cr.2010.150.

[48] Xu F, Zhang C, Zou Z, Fan EKY, Chen L, Li Y, et al. Aging-related Atg5 defect impairs neutrophil extracellular traps formation. Immunology. 2017; 151: 417-32. https://doi.org/10.1111/imm.12740.

[49] Mao JY, Zhang JH, Cheng W, Chen JW, Cui N. Effects of neutrophil extracellular traps in patients with septic coagulopathy and their interaction with autophagy. Front Immunol. 2021; 12: 757041. https://doi.org/10.3389/fimmu.2021.757041.

[50] Park SY, Shrestha S, Youn YJ, Kim JK, Kim SY, Kim HJ, et al. Autophagy primes neutrophils for neutrophil extracellular trap formation during sepsis. Am J Respir Crit Care Med. 2017; 196: 577-89. https://doi.org/10.1164/rccm.201603-0596OC.

[51] Wu MY, Lu JH. Autophagy and macrophage functions: inflammatory response and phagocytosis. Cell. 2019;9. https://doi.org/10.3390/cells9010070.

[52] Fei Q, Ma H, Zou J, Wang W, Zhu L, Deng H, et al. Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages. J Mol Cell Cardiol. 2020; 145: 1-13. https://doi.org/10.1016/j.yjmcc.2020.05.016.

[53] Lv S, Liu H, Wang H. The interplay between autophagy and NLRP3 Inflammasome in ischemia/reperfusion injury. Int J Mol Sci. 2021; 22. https://doi.org/10.3390/ijms22168773.

[54] Xia Y, Liu N, Xie X, Bi G, Ba H, Li L, et al. The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion. Autophagy. 2019; 15: 960-75. https://doi.org/10.1080/15548627.2019.1569916.

[55] Zhang Z, Yue P, Lu T, Wang Y, Wei Y, Wei X. Role of lysosomes in physiological activities, diseases, and therapy. J Hematol Oncol. 2021; 14: 79. https://doi.org/10.1186/s13045-021-01087-1.

[56] Javaheri A, Bajpai G, Picataggi A, Mani S, Foroughi L, Evie H, et al. TFEB activation in macrophages attenuates postmyocardial infarction ventricular dysfunction independently of ATG5-mediated autophagy. JCI Insight. 2019; 4. https://doi.org/10.1172/jci.insight.127312.

[57] Liu C, Wang Y, Li L, He D, Chi J, Li Q, et al. Engineered extracellular vesicles and their mimetics for cancer immunotherapy. J Control Release. 2022; 349: 679-98. https://doi.org/10.1016/j.jconrel.2022.05.062.

[58] Yang G, Song W, Postoak JL, Chen J, Martinez J, Zhang J, et al. Autophagy-related protein PIK3C3/VPS34 controls T cell metabolism and function. Autophagy. 2021; 17: 1193-204. https://doi.org/10.1080/15548627.2020.1752979.

[59] Dowling SD, Macian F. Autophagy and T cell metabolism. Cancer Lett. 2018; 419: 20-6. https://doi.org/10.1016/j.canlet.2018.01.033.

[60] Lin CW, Lo S, Hsu C, Hsieh CH, Chang YF, Hou BS, et al. T-cell autophagy deficiency increases mortality and suppresses immune responses after sepsis. PLoS One. 2014; 9: e102066. https://doi.org/10.1371/journal.pone.0102066.

[61] Wei J, Long L, Yang K, Guy C, Shrestha S, Chen Z, et al. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat Immunol. 2016; 17: 277-85. https://doi.org/10.1038/ni.3365.

[62] Zhuang R, Feinberg MW. Regulatory T cells in ischemic cardiovascular injury and repair. J Mol Cell Cardiol. 2020; 147: 1-11. https://doi.org/10.1016/j.yjmcc.2020.08.004.

[63] Xia N, Lu Y, Gu M, Li N, Liu M, Jiao J, et al. A unique population of regulatory T cells in heart potentiates cardiac protection from myocardial infarction. Circulation. 2020; 142: 1956-73. https://doi.org/10.1161/CIRCULATIONAHA.120.046789.

[64] Wang Y, Lu J, Cheng W, Gao R, Yang L, Yang Z. FK506 protects heart function via increasing autophagy after myocardial infarction in mice. Biochem Biophys Res Commun. 2017; 493: 1296-303. https://doi.org/10.1016/j.bbrc.2017.09.155.

[65] Wei YX, Dong SM, Wang YY, Zhang P, Sun MY, Wei YX, et al. Autophagy participates in the protection role of 1,25-dihydroxyvitamin D3 in acute myocardial infarction via PI3K/AKT/mTOR pathway. Cell Biol Int. 2021; 45: 394-403. https://doi.org/10.1002/cbin.11495.

[66] Fang J, Wang J, Chen F, Xu Y, Zhang H, Wang Y. alpha7nAChR deletion aggravates myocardial infarction and enhances systemic inflammatory reaction via mTOR-Signaling-related autophagy. Inflammation. 2019; 42: 1190-202. https://doi.org/10.1007/s10753-019-00979-2.

[67] Li X, Li Z, Li B, Zhu X, Lai X. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway. Life Sci. 2019; 234: 116773. https://doi.org/10.1016/j.lfs.2019.116773.

[68] Peng M, Liu Y, Xu Y, Li L, Li Y, Yang H. Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome. Cell Cycle. 2021; 20: 2278-90. https://doi.org/10.1080/15384101.2021.1981631.

[69] Zhang H, Chen X, Zong B, Yuan H, Wang Z, Wei Y, et al. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. J Cell Mol Med. 2018; 22: 4437-48. https://doi.org/10.1111/jcmm.13743.

[70] Li X, Ke X, Li Z, Li B. Vaspin prevents myocardial injury in rats model of diabetic cardiomyopathy by enhancing autophagy and inhibiting inflammation. Biochem Biophys Res Commun. 2019; 514: 1-8. https://doi.org/10.1016/j.bbrc.2019.04.110.

[71] Yang F, Qin Y, Wang Y, Meng S, Xian H, Che H, et al. Metformin inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent effects in diabetic cardiomyopathy. Int J Biol Sci. 2019; 15: 1010-9. https://doi.org/10.7150/ijbs.29680.

[72] Wang X, Xu Y, Li L, Lu W. Thrombin aggravates hypoxia/Reoxygenation injury of Cardiomyocytes by activating an autophagy pathway-mediated by SIRT1. Med Sci Monit. 2021; 27: e928480. https://doi.org/10.12659/MSM.928480.

[73] Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis-diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015; 12: 670-80. https://doi.org/10.1038/nrcardio.2015.108.

[74] Knowlton KU. CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol. 2008; 323: 315-35. https://doi.org/10.1007/978-3-540-75546-3_15.

[75] Duque TLA, Cascabulho CM, Oliveira GM, Henriques-Pons A, Menna-Barreto RFS. Rapamycin treatment reduces acute myocarditis induced by Trypanosoma cruzi infection. J Innate Immun. 2020; 12: 321-32. https://doi.org/10.1159/000504322.

[76] Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol. 2011; 46: 549-59. https://doi.org/10.1016/j.exger.2011.02.010.

[77] Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, et al. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Circulation. 2008; 118: 818-27. https://doi.org/10.1161/CIRCULATIONAHA.107.717702.

[78] Liu CP, Yeh JL, Wu BN, Chai CY, Chen IJ, Lai WT. KMUP-3 attenuates ventricular remodelling after myocardial infarction through eNOS enhancement and restoration of MMP-9/TIMP-1 balance. Br J Pharmacol. 2011; 162: 126-35. https://doi.org/10.1111/j.1476-5381.2010.01024.x.

[79] Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M, et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2004; 286: H276-82. https://doi.org/10.1152/ajpheart.00129.2003.

[80] Shao J, Miao C, Geng Z, Gu M, Wu Y, Li Q. Effect of eNOS on ischemic Postconditioning-induced autophagy against ischemia/reperfusion injury in mice. Biomed Res Int. 2019; 2019: 5201014. https://doi.org/10.1155/2019/5201014.

[81] Wu D, Ji H, Du W, Ren L, Qian G. Mitophagy alleviates ischemia/reperfusion-induced microvascular damage through improving mitochondrial quality control. Bioengineered. 2022; 13: 3596-607. https://doi.org/10.1080/21655979.2022.2027065.

[82] Jeong IH, Bae WY, Choi JS, Jeong JW. Ischemia induces autophagy of endothelial cells and stimulates angiogenic effects in a hindlimb ischemia mouse model. Cell Death Dis. 2020; 11: 624. https://doi.org/10.1038/s41419-020-02849-4.

[83] Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and Mitophagy in cardiovascular disease. Circ Res. 2017; 120: 1812-24. https://doi.org/10.1161/CIRCRESAHA.117.311082.

[84] Liu T, Han S, Dai Q, Zheng J, Liu C, Li S, et al. IL-17A-mediated excessive autophagy aggravated neuronal ischemic injuries via Src-PP2B-mTOR pathway. Front Immunol. 2019; 10: 2952. https://doi.org/10.3389/fimmu.2019.02952.

[85] He J, Liu D, Zhao L, Zhou D, Rong J, Zhang L, et al. Myocardial ischemia/reperfusion injury: mechanisms of injury and implications for management (review). Exp Ther Med. 2022; 23: 430. https://doi.org/10.3892/etm.2022.11357.

[86] Tibaut M, Mekis D, Petrovic D. Pathophysiology of myocardial infarction and acute management strategies. Cardiovasc Hematol Agents Med Chem. 2017; 14: 150-9. https://doi.org/10.2174/1871525714666161216100553.

[87] Wang X, Guo Z, Ding Z, Mehta JL. Inflammation, autophagy, and apoptosis after myocardial infarction. J Am Heart Assoc. 2018; 7. https://doi.org/10.1161/JAHA.117.008024.

[88] Zhong Z, Luo XY, Xiang P, Ji HH, Wu XD, Chong AG, et al. MRTF-A alleviates myocardial ischemia reperfusion injury by inhibiting the inflammatory response and inducing autophagy. Mol Cell Biochem. 2022. https://doi.org/10.1007/s11010-022-04510-4.

[89] Bai YD, Yang YR, Mu XP, Lin G, Wang YP, Jin S, et al. Hydrogen Sulfide alleviates acute myocardial ischemia injury by modulating autophagy and inflammation response under oxidative stress. Oxidative Med Cell Longev. 2018; 2018: 3402809. https://doi.org/10.1155/2018/3402809.

[90] Xiang M, Lu Y, Xin L, Gao J, Shang C, Jiang Z, et al. Role of oxidative stress in reperfusion following myocardial ischemia and its treatments. Oxidative Med Cell Longev. 2021; 2021: 6614009. https://doi.org/10.1155/2021/6614009.

[91] Li L, Tan J, Miao Y, Lei P, Zhang Q. ROS and Autophagy: interactions and molecular regulatory mechanisms. Cell Mol Neurobiol. 2015; 35: 615-21. https://doi.org/10.1007/s10571-015-0166-x.

[92] Furian T, Aguiar C, Prado K, Ribeiro RV, Becker L, Martinelli N, et al. Ventricular dysfunction and dilation in severe sepsis and septic shock: relation to endothelial function and mortality. J Crit Care. 2012; 27: 319 e9-15. https://doi.org/10.1016/j.jcrc.2011.06.017.

[93] Hsieh CH, Pai PY, Hsueh HW, Yuan SS, Hsieh YC. Complete induction of autophagy is essential for cardioprotection in sepsis. Ann Surg. 2011; 253: 1190-200. https://doi.org/10.1097/SLA.0b013e318214b67e.

[94] Busch K, Kny M, Huang N, Klassert TE, Stock M, Hahn A, et al. Inhibition of the NLRP3/IL-1beta axis protects against sepsis-induced cardiomyopathy. J Cachexia Sarcopenia Muscle. 2021; 12: 1653-68. https://doi.org/10.1002/jcsm.12763.

[95] Biasizzo M, Kopitar-Jerala N. Interplay between NLRP3 Inflammasome and autophagy. Front Immunol. 2020; 11: 591803. https://doi.org/10.3389/fimmu.2020.591803.

[96] Wong YC, Kim S, Peng W, Krainc D. Regulation and function of mitochondria-lysosome membrane contact sites in cellular homeostasis. Trends Cell Biol. 2019; 29: 500-13. https://doi.org/10.1016/j.tcb.2019.02.004.

[97] Wu B, Song H, Fan M, You F, Zhang L, Luo J, et al. Luteolin attenuates sepsis-induced myocardial injury by enhancing autophagy in mice. Int J Mol Med. 2020; 45: 1477-87. https://doi.org/10.3892/ijmm.2020.4536.

[98] Pan P, Wang X, Liu D. The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy. J Int Med Res. 2018; 46: 2157-69. https://doi.org/10.1177/0300060518765896.

[99] Kaur N, Guan Y, Raja R, Ruiz-Velasco A, Liu W. Mechanisms and therapeutic prospects of diabetic cardiomyopathy through the inflammatory response. Front Physiol. 2021; 12: 694864. https://doi.org/10.3389/fphys.2021.694864.

[100] Kanamori H, Takemura G, Goto K, Tsujimoto A, Mikami A, Ogino A, et al. Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes. Autophagy. 2015; 11: 1146-60. https://doi.org/10.1080/15548627.2015.1051295.

[101] Xu X, Kobayashi S, Chen K, Timm D, Volden P, Huang Y, et al. Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes. J Biol Chem. 2013; 288: 18077-92. https://doi.org/10.1074/jbc.M113.474650.

[102] Asnani A. Activating autophagy to prevent doxorubicin cardiomyopathy: the timing matters. Circ Res. 2021; 129: 801-3. https://doi.org/10.1161/CIRCRESAHA.121.320063.

[103] Wallace KB, Sardao VA, Oliveira PJ. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ Res. 2020; 126: 926-41. https://doi.org/10.1161/CIRCRESAHA.119.314681.

[104] Bartlett JJ, Trivedi PC, Pulinilkunnil T. Autophagic dysregulation in doxorubicin cardiomyopathy. J Mol Cell Cardiol. 2017; 104: 1-8. https://doi.org/10.1016/j.yjmcc.2017.01.007.

[105] Piper SE, McDonagh TA. Chemotherapy-related cardiomyopathy. Eur Cardiol. 2015; 10: 19-24. https://doi.org/10.15420/ecr.2015.10.01.19.

[106] Pascual-Figal DA, Bayes-Genis A, Asensio-Lopez MC, Hernandez-Vicente A, Garrido-Bravo I, Pastor-Perez F, et al. The Interleukin-1 Axis and risk of death in patients with acutely decompensated heart failure. J Am Coll Cardiol. 2019; 73: 1016-25. https://doi.org/10.1016/j.jacc.2018.11.054.

[107] Frantz S, Bauersachs J, Kelly RA. Innate immunity and the heart. Curr Pharm Des. 2005; 11: 1279-90. https://doi.org/10.2174/1381612053507512.

[108] Ma Y, Zhang X, Bao H, Mi S, Cai W, Yan H, et al. Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. PLoS One. 2012; 7: e40763. https://doi.org/10.1371/journal.pone.0040763.

[109] Stahli BE, Klingenberg R, Heg D, Branca M, Manka R, Kapos I, et al. Mammalian target of rapamycin inhibition in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2022; 80: 1802-14. https://doi.org/10.1016/j.jacc.2022.08.747.

[110] Khan M, Mohan IK, Kutala VK, Kotha SR, Parinandi NL, Hamlin RL, et al. Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation. Antioxid Redox Signal. 2009; 11: 725-38. https://doi.org/10.1089/ARS.2008.2155.

[111] Cohen R, Shainberg A, Hochhauser E, Cheporko Y, Tobar A, Birk E, et al. UTP reduces infarct size and improves mice heart function after myocardial infarct via P2Y2 receptor. Biochem Pharmacol. 2011; 82: 1126-33. https://doi.org/10.1016/j.bcp.2011.07.094.

[112] Gao G, Chen W, Yan M, Liu J, Luo H, Wang C, et al. Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling. Int J Mol Med. 2020; 45: 195-209. https://doi.org/10.3892/ijmm.2019.4407.

[113] Sun B, Xu Y, Liu ZY, Meng WX, Yang H. Autophagy assuages myocardial infarction through Nrf2 signaling activation-mediated reactive oxygen species clear. Eur Rev Med Pharmacol Sci. 2020; 24: 7381-90. https://doi.org/10.26355/eurrev_202007_21906.

[114] Xie F, Xu S, Lu Y, Wong KF, Sun L, Hasan KMM, et al. Metformin accelerates zebrafish heart regeneration by inducing autophagy. NPJ Regen Med. 2021; 6: 62. https://doi.org/10.1038/s41536-021-00172-w.

[115] Wu XQ, He LS, Cai Y, Zhang GP, He YL, Zhang ZJ, et al. Induction of autophagy contributes to the myocardial protection of valsartan against ischemia-reperfusion injury. Mol Med Rep. 2013; 8: 1824-30. https://doi.org/10.3892/mmr.2013.1708.

[116] Cohen IV, Makunts T, Moumedjian T, Issa MA, Abagyan R. Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports. Sci Rep-Uk. 2020;10 ARTN 19199. https://doi.org/10.1038/s41598-020-76258-0.